Inger M.
- Country
- Denmark
- Department
- Infectious Diseases
Research Overview
- Phase 2 Randomized Double‑Blind Study of VX-828/Deutivacaftor With and Without Tezacaftor in Adults with Cystic Fibrosis
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Long‑Acting bNAbs 10‑1074‑LS and 3BNC117‑LS with Low‑Dose Nivolumab for Durable HIV‑1 Remission during ART Interruption
- Evaluation of Long-term Safety and Efficacy of Tezacaftor, Deutivacaftor, and Vanzacaftor Combination Therapy in Patients with Cystic Fibrosis
Data & Insights
Has run more than one trial at 36 of 140 partner sites.
Specializations
Infectious Diseases and Antimicrobial Therapy
The investigator is involved in clinical research on viral infection, bacterial infection, and complex pulmonary infection management, with particular interest in treatment strategies for COVID-19, sepsis, septic shock, and Mycobacterium abscessus lung disease.
- COVID-19 and severe respiratory infection
- Sepsis and septic shock
- Mycobacterium abscessus pulmonary disease
- Bacterial brain abscess and pleural empyema
Research activity also extends to infection-related complications in hospitalized patients and the evaluation of therapeutic options for difficult-to-treat infectious conditions.
Hematologic Malignancies and Cell Therapy
The clinical portfolio includes extensive work in acute leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, together with interest in CAR T-cell therapy and other advanced hematologic treatment approaches.
- Acute lymphoblastic leukemia and acute myeloid leukemia
- B-cell lymphoma and Hodgkin lymphoma
- Multiple myeloma and plasma cell myeloma
- Gene-modified T cells and cellular immunotherapy
Therapeutic interest also includes relapsed or refractory blood cancers, pediatric hematology-oncology, and post-transplant immune complications such as graft-versus-host disease.
Cardiovascular Medicine and Thrombosis
The investigator is active in studies of acute myocardial infarction, cardiac arrest, atrial fibrillation, heart failure, and pulmonary embolism, with a clear focus on interventions that address cardiovascular risk and thrombotic burden.
- Myocardial infarction and coronary artery disease
- Out-of-hospital cardiac arrest and idiopathic ventricular fibrillation
- Pulmonary embolism and pulmonary hypertension
- Atherosclerotic plaque and antiplatelet therapy
Additional involvement includes cardiovascular outcomes after surgery, structural heart disease, and prevention of recurrent ischemic events.
Neurology, Autoimmune Disease, and Rare Disorders
Research interests cover multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, vasculitis, and selected rare neurologic and genetic disorders, reflecting a strong therapeutic focus on immune-mediated and inherited disease.
- Multiple sclerosis and relapsing disease
- Generalized myasthenia gravis
- Chronic inflammatory demyelinating polyneuropathy
- Rare genetic neurologic disease and autoimmune vasculitis
The portfolio also includes stroke, headache disorders, and other inflammatory conditions requiring targeted therapeutic development.
Oncology and Pediatric Solid Tumors
The investigator participates in research across solid tumors, including lung cancer, breast cancer, colorectal cancer, ovarian cancer, and prostate cancer, with additional attention to pediatric and adolescent tumor types.
- Non-small cell lung cancer and small cell lung cancer
- Breast cancer and endometrial cancer
- Prostate cancer and urothelial carcinoma
- Glioma, medulloblastoma, and neuroblastoma
Therapeutic interests include immuno-oncology, targeted cancer therapy, and treatment approaches for advanced, recurrent, or metastatic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.